CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MACOV project focuses on developing an innovative macrophage-based therapy for platinum-resistant ovarian cancer. This groundbreaking treatment aims to deliver targeted therapy directly to cancer cells, addressing a significant unmet medical need.
Resistance to platinum-based chemotherapy is a major clinical challenge in ovarian cancer.
About 300,000 women are diagnosed with ovarian cancer each year and the number of deaths is estimated at 180,000 worldwide each year.
Ovarian cancer metastasizes early in its development, often before it's diagnosed.
Ovarian cancer treatment involves surgery with frontline platinum-based chemotherapy.
As many as 15-30% of patients with ovarian cancer have primary platinum-resistant or refractory disease. T…
CELLIS SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
